COS7 antibodies are polyclonal or monoclonal antibodies targeting proteins either endogenous to COS-7 cells or expressed via transfection. Key applications include:
Immunoblotting: Detecting protein expression levels (e.g., SV40 T-antigen, steroidogenic enzymes) .
Immunofluorescence: Localizing proteins in cellular compartments (e.g., JC virus VP1 capsid protein) .
Functional Studies: Investigating protein-protein interactions, enzymatic activity, or viral replication mechanisms .
COS7 antibodies are used to study diverse biological processes, as demonstrated in recent studies:
JC Virus VP1: Antibodies against VP1 (e.g., ab34756) confirmed viral replication in COS-7 cells via Western blot and immunofluorescence, showing nuclear localization during infection .
SV40 T-antigen: Critical for COS-7 cell transfection efficiency, detected using antibodies in nuclear extract studies .
HIF-1 Activation: COS-7 nuclear extracts treated with CoCl₂ showed HIF-1 upregulation, detected using TransAM® HIF kits .
Renin-Angiotensin System (RAS): COS7 antibodies confirmed endogenous expression of ACE, ACE2, and renin, with mass spectrometry validating enzymatic activity .
Steroidogenic Enzymes: RT-PCR and Western blotting revealed COS-7 cells metabolize steroids via 3β-HSD and 17β-HSD pathways .
Viral Vector Development: Antibodies against SV40 components enabled optimization of viral progeny production in gene therapy studies .
KEGG: sce:YDL248W
STRING: 4932.YDL248W
COS-7 is a fibroblast-like cell line derived from the kidney of the African green monkey (Cercopithecus aethiops). This cell line is widely used in research because it's robust, easily propagated, and highly amenable to genetic manipulation. The versatility of COS-7 cells allows researchers to study functional regulation of single genes and reconstitute multiprotein complexes . The transfectable nature of this cell line makes it particularly attractive for studying molecular, functional, and pharmacological properties of various biological systems .
For reliable immunofluorescence results with COS-7 cells, researchers can employ several validated protocols:
Protocol A (Paraformaldehyde-based fixation):
Grow cells to 70% confluence on glass coverslips in multi-well plates
Fix cells in 4% paraformaldehyde at room temperature for 15 minutes
Permeabilize with 0.5% Triton X-100 for 5 minutes
Block with appropriate blocking buffer for 1 hour at room temperature
Incubate with primary antibody overnight at 4°C
Wash with PBS three times
Incubate with fluorophore-conjugated secondary antibody for 30 minutes in darkness
Add nuclear counterstain (e.g., DAPI 1:1,000) for 5 minutes
Protocol B (Methanol-based fixation):
Grow cells to 70% confluence on glass coverslips
Fix in absolute methanol and permeabilize with 4% paraformaldehyde containing 0.25% Triton X-100
Incubate at 4°C for 20 minutes
Wash with cold PBS solution
Block using 3% normal donkey serum for 1 hour at 4°C
Incubate with primary antibodies at appropriate dilutions
Wash and incubate with secondary antibodies
For optimal Western blot analysis of COS-7 cell lysates:
Extract total protein from approximately 1×10^6 COS-7 cells
Quantify protein concentration using BCA protein assay kit
Load equal amounts of protein (typically 15 μg) per lane
Separate proteins by SDS-PAGE
Transfer to appropriate membrane (e.g., PVDF)
Block with 5% non-fat dry milk or 5% BSA for 1 hour at room temperature
Incubate with primary antibody diluted in 3% BSA overnight at 4°C
Wash with TBST buffer
Incubate with appropriate HRP-conjugated secondary antibody for 1 hour at room temperature
Detect signals with enhanced chemiluminescence reagents
Normalize protein levels to housekeeping proteins (typically GAPDH)
Researchers can effectively track viral protein expression in COS-7 cells using a combination of Western blot and immunofluorescence approaches:
Western blot approach:
Collect infected COS-7 cells at specific time points post-infection
Extract total protein and quantify
Perform Western blot analysis using antibodies against viral proteins
Monitor temporal changes in viral protein expression
For example, in JC virus studies, researchers detected capsid protein VP1 as early as 7 days post-infection with expression increasing steadily, reaching maximum levels at 21 days post-infection .
Immunofluorescence approach:
Fix infected COS-7 cell monolayers with 4% paraformaldehyde
Permeabilize with 0.3% Triton X-100 in PBS for 10 minutes
Incubate with primary antibody against viral proteins (e.g., anti-VP1 at 1:250 dilution)
Visualize using fluorescent secondary antibodies (e.g., Alexa Fluor 568)
Counterstain nuclei with DAPI
Image using confocal microscopy to determine subcellular localization of viral proteins
When investigating endogenous protein expression in COS-7 cells:
Antibody selection:
Choose antibodies validated for use in non-human primate cells
Consider antibodies raised against conserved epitopes when studying proteins with high homology between species
Verify cross-reactivity with monkey proteins (COS-7 is derived from African green monkey)
Validation strategies:
Include appropriate negative controls (omitting primary antibody)
When possible, use multiple antibodies targeting different epitopes of the same protein
Consider RNAi knockdown controls to confirm specificity
Optimization of protocols:
Determine optimal antibody dilutions (typically 1:250-1:500 for immunofluorescence, 1:1000-1:5000 for Western blot)
Test different fixation methods (paraformaldehyde vs. methanol)
Optimize blocking conditions to reduce background
Data interpretation:
Researchers can employ several antibody-based approaches to investigate protein-protein interactions in COS-7 cells:
Immunoprecipitation:
Prepare cell lysates under non-denaturing conditions
Pre-clear lysates with protein A/G beads
Incubate with antibody against protein of interest
Capture antibody-protein complexes with protein A/G beads
Wash extensively to remove non-specific interactions
Elute bound proteins and analyze by Western blot
Co-immunofluorescence:
Perform immunofluorescence with antibodies against two proteins of interest
Use differentially labeled secondary antibodies
Analyze co-localization using confocal microscopy and image analysis software
Proximity Ligation Assay (PLA):
This technique provides higher sensitivity for detecting protein-protein interactions within 40 nm distance:
Incubate fixed cells with primary antibodies against two proteins of interest
Add PLA probes (secondary antibodies with oligonucleotide tails)
Add circle-forming DNA oligonucleotides that hybridize to PLA probes
Perform rolling circle amplification
Detect amplified DNA with fluorescent probes
In a study of Cdk5 activation, researchers used immunoprecipitation with anti-Cdk5 antibody followed by kinase activity assays to demonstrate the functional interaction between Cdk5 and its activator p35 .
COS-7 cells endogenously express components of the RAS, making them valuable for studying this system. Key approaches include:
Transcript level analysis:
Reverse transcription coupled to gene-specific PCR to detect expression of ACE, ACE2, AT1R, and renin transcripts
Protein expression analysis:
Western blot and immunohistochemistry to identify ACE (60 kDa), ACE2 (75 kDa), AT1R (43 kDa), renin (41 kDa), and ADAM17 (130 kDa)
Functional enzymatic assays:
For ACE activity: Incubate COS-7 cell lysates in MES buffer (pH 6.75) with PMSF and angiotensin I substrate
For ACE2 activity: Incubate lysates in bicine buffer (pH 7.6) with protease inhibitors and angiotensin II substrate
Analyze reaction products using sensitive mass spectrometric approaches
| Protein | Molecular Weight | Detection Methods | Antibody Source |
|---|---|---|---|
| ACE | 60 kDa | WB, IF, Enzymatic | Santa Cruz (sc-12187) |
| ACE2 | 75 kDa | WB, IF, Enzymatic | Santa Cruz (sc-21834) |
| AT1R | 43 kDa | WB, IF | Various |
| Renin | 41 kDa | WB, IF, Enzymatic | Santa Cruz (sc-27318) |
| ADAM17 | 130 kDa | WB | Various |
WB = Western blot; IF = Immunofluorescence
Antibodies play a central role in studying Cdk5 activation and neuronal differentiation in COS-7 cells:
Kinase activity assessment:
Immunoprecipitate Cdk5 using specific antibodies
Perform kinase activity assays using Histone H1 as substrate
Detect phosphorylation using [γ-32P] ATP and phosphocellulose pad-based methods
Quantify 32P phospho-Histone H1 levels as a measure of Cdk5 activity
Neuronal marker detection:
Use immunofluorescence and Western blot with antibodies against neuronal markers to track transition toward neuronal-like phenotype
Monitor morphological changes using microscopy
Signaling pathway analysis:
Investigate NGF expression and related signaling using anti-NGF antibodies
Track activation of downstream effectors
Research has demonstrated that p35 overexpression significantly increases Cdk5 kinase activity in COS-7 cells and induces expression of neuronal-like cell markers, suggesting these cells can transition toward a neuronal phenotype under appropriate conditions .
When encountering nonspecific binding in COS-7 cells:
Optimize blocking conditions:
Test different blocking agents (BSA, normal serum, commercial blockers)
Increase blocking time or concentration
Add 0.1-0.3% Triton X-100 to blocking solution to reduce hydrophobic interactions
Adjust antibody parameters:
Titrate primary antibody concentrations
Reduce incubation time or temperature
Pre-absorb antibody with cell lysate from non-expressing cells
Modify washing protocols:
Increase number and duration of washes
Add low concentrations of detergent to wash buffers
Use high-salt wash buffers to disrupt low-affinity interactions
Refine fixation techniques:
Compare different fixation methods (4% paraformaldehyde, methanol, or combination)
Adjust permeabilization conditions (vary Triton X-100 concentration from 0.1-0.5%)
For phospho-specific antibodies, include phosphatase inhibitors in buffers
Validate with controls:
Include samples with target protein knockdown or knockout
Compare patterns with multiple antibodies against the same target
For monitoring virus replication in COS-7 cells, researchers can implement these antibody-based approaches:
Viral protein detection timeline:
Infect COS-7 cells with virus of interest
Collect cells and supernatants at regular intervals (e.g., weekly)
Perform Western blot analysis using antibodies against viral proteins
Quantify protein expression using densitometry
For JC virus studies, VP1 capsid protein was first detected in cell lysates at 7 days post-infection, with levels increasing until reaching maximum expression at 21 days post-infection. VP1 was detected in supernatants starting at 14 days post-infection, indicating release of viral particles .
Viral DNA quantification with protein correlation:
Combine antibody detection of viral proteins with qPCR for viral DNA to establish correlations between viral replication and protein expression.
| Days Post-Infection | Intracellular Viral Load (gEq/cell DNA) | Supernatant Viral Load (gEq/ml) | VP1 Expression in Cells | VP1 in Supernatant |
|---|---|---|---|---|
| 4 | 4.96×10¹ | Not reported | Not detected | Not detected |
| 7 | Not reported | Not reported | Detected | Not detected |
| 14 | Not reported | Not reported | Increasing | First detected |
| 21 | Not reported | Not reported | Maximum | Present |
| 35 | 1.60×10³ | 5.59×10⁶ | Present | Present |
To ensure antibody specificity in COS-7 cells:
Gene knockdown validation:
Transfect cells with siRNA or shRNA targeting the protein of interest
Compare antibody staining between knockdown and control cells
Significant reduction in signal confirms specificity
Overexpression controls:
Transfect cells with expression vectors for the target protein
Compare antibody staining between transfected and non-transfected cells
Signal increase in transfected cells supports specificity
Peptide competition assays:
Pre-incubate antibody with excess purified antigen or immunizing peptide
Apply to parallel samples
Specific binding should be blocked by competition
Multiple antibody validation:
Test multiple antibodies recognizing different epitopes of the same protein
Concordant results increase confidence in specificity
Western blot correlation: